Ariane Lacerda

Dr. Ariane Lacerda


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2014 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
ALAriane Lacerda
Ariane Lacerda
ÃVÉRico A. R. Vasconcelos
ÉRico A. R. Vasconcelos
PPPatrícia Pelegrini
Patrícia Pelegrini
Maria Fatima Grossi–de–SaMaria Fatima Grossi–de–Sa
Maria Fatima Grossi–de–Sa
Since the beginning of the 90’s lots of cationic plant, cysteine-rich antimicrobial peptides (AMP) have been studied. However, Broekaert only coined the term “plant defensin” in 1995, after comparison of a new class of plant antifungal peptides with known insect defensins. From there, many plant defensins have been reported and studies on this class of peptides encompass its activity towards microorganisms and molecular features of the mechanism of action against bacteria and fungi. Plant defensins also have been tested as biotechnological tools to improve crop production through fungi resistance generation in organisms genetically modified (OGM). Its low effective concentration towards fungi, ranging from 0.1 to 10 µM and its safety to mammals and birds makes them a better choice, in place of chemicals, to control fungi infection on crop fields. Herein, is a review of the history of plant defensins since their discovery at the beginning of 90’s, following the advances on its structure conformation and mechanism of action towards microorganisms is reported. This review also points out some important topics, including: (i) the most studied plant defensins and their fungal targets; (ii) the molecular features of plant defensins and their relation with antifungal activity; (iii) the possibility of using plant defensin(s) genes to generate fungi resistant GM crops and biofungicides; and (iv) a brief discussion about the absence of products in the market containing plant antifungal defensins.

24 November 2023 in Foods
Verified
Journal Article
Open access
PDF file
ARAdriano Henrique do Nascimento Rangel
Adriano Henrique do Nascimento Rangel
DBDébora América Frezza Villar de Araújo Bezerra
Débora América Frezza Villar de Araújo Bezerra
DSDanielle Cavalcanti Sales
Danielle Cavalcanti Sales
EAEmmanuella de Oliveira Moura Araújo
Emmanuella de Oliveira Moura Araújo
LLLuis Medeiros de Lucena
Luis Medeiros de Lucena
KAKatya Anaya
Katya Anaya
The search for improvements in quality of life has increasingly involved changes in the diet, especially the consumption of foods which, in addition to having good nutritional value, are characterized by offering health benefits. Among the molecules that trigger several beneficial responses are peptides, which are specific fragments of proteins known to produce positive effects on the human body. This review aimed to discuss the bioactive potential of peptides from cheeses. Studies show that the protein composition of some cheese varieties exhibits a potential for the release of bioactive peptides. The production of these peptides can be promoted by some technological procedures that affect the milk structure and constituents. The cheese maturation process stands out for producing bioactive peptides due to the action of enzymes produced by lactic acid bacteria. Thus, in addition to being proteins with high biological value due to their excellent amino acid profile, peptides from some types of cheeses are endowed with functional properties such as anti-hypertensive, antimicrobial, antioxidant, anticarcinogenic, opioid, and zinc-binding activities.

1 October 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MTManoela Torres-Rêgo
Manoela Torres-Rêgo
FGFiamma Gláucia-Silva
Fiamma Gláucia-Silva
KSKarla Samara Rocha Soares
Karla Samara Rocha Soares
LSLuanda Bárbara Ferreira Canário de Souza
Luanda Bárbara Ferreira Canário de Souza
IDIgor Zumba Damasceno
Igor Zumba Damasceno
MPMatheus Pedrosa
Matheus Pedrosa

29 September 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ARTHUR de MEDEIROSARTHUR de MEDEIROS
ARTHUR de MEDEIROS
MTManoela Torres-Rêgo
Manoela Torres-Rêgo
ALAriane Lacerda
Ariane Lacerda
Hugo Alexandre Oliveira RochaHugo Alexandre Oliveira Rocha
Hugo Alexandre Oliveira Rocha
EEEryvaldo Socrates Egito
Eryvaldo Socrates Egito
Arnobio Antonio Da Silva-JuniorArnobio Antonio Da Silva-Junior
Arnobio Antonio Da Silva-Junior
This study assesses the efficacy of different nanoemulsion formulations as new and innovative adjuvants for improving the in vivo immunization against the Tityus serrulatus scorpion venom. Nanoemulsions were designed testing key-variables such as surfactants, co-solvents, and the influence of the temperature, which would be able to induce the phase transition from a liquid crystal to a stable nanoemulsion, assessed for four months. Additionally, cationic-covered nanoemulsion with hyper-branched poly(ethyleneimine) was prepared and its performance was compared to the non-cationic ones. The physicochemical properties of the selected nanoemulsions and the interactions among their involved formulation compounds were carefully monitored. The cytotoxicity studies in murine macrophages (RAW 264.7) and red blood cells were used to compare different formulations. Moreover, the performance of the nanoemulsion systems as biocompatible adjuvants was evaluated using mice immunization protocol. The FTIR shifts and the zeta potential changes (from −18.3 ± 1.0 to + 8.4 ± 1.4) corroborated with the expected supramolecular anchoring of venom proteins on the surface of the nanoemulsion droplets. Cell culture assays demonstrated the non-toxicity of the formulations at concentrations less than 1.0 mg/mL, which were able to inhibit the hemolytic effect of the scorpion venom. The cationic-covered nanoemulsion has shown superior adjuvant activity, revealing the highest IgG titer in the immunized animals compared to both the non-cationic counterpart and the traditional aluminum adjuvant. In this approach, we demonstrate the incredible potential application of nanoemulsions as adjuvants, using a nanotechnology platform for antigen delivery system on immune cells. Additionally, the functionalization with hyper-branched poly(ethyleneimine) enhances this recognition and improves its action in immunization.